Nuzenio

Iovance

Iovance news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Is Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:32:06 GMTIovance Biotherapeutics (IOVA) Stock Price Trails Record Revenue And Margin Gains - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:28:31 GMTState Street Corporation (NYSE: STT) discloses 5.5% Iovance Biotherapeutics stake - Stock TitanStock Titan · Fri, 07 Aug 2026 13:57:10 GMTDoes Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:55:02 GMTIovance Biotherapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:30:00 GMTAfter IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 06:22:11 GMTWhy Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today? - TradingViewTradingView · Fri, 07 Aug 2026 02:40:00 GMTIovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highl - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:34:12 GMT

Timeline

Sun, 09 Aug 2026 11:32:06 GMTIs Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - simplywall.st
Sat, 08 Aug 2026 00:28:31 GMTIovance Biotherapeutics (IOVA) Stock Price Trails Record Revenue And Margin Gains - simplywall.st
Fri, 07 Aug 2026 13:57:10 GMTState Street Corporation (NYSE: STT) discloses 5.5% Iovance Biotherapeutics stake - Stock Titan
Fri, 07 Aug 2026 13:55:02 GMTDoes Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect? - Yahoo Finance
Fri, 07 Aug 2026 12:30:00 GMTIovance Biotherapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fri, 07 Aug 2026 06:22:11 GMTAfter IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - stocktwits.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Iovance.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.